TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bionord Biokemi AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
63,621
|
65,408
|
69,738 |
| Financial expenses |
0
|
2
|
10 |
| Earnings before taxes |
7,538
|
7,042
|
7,164 |
| EBITDA |
7,463
|
7,048
|
7,226 |
| Total assets |
28,210
|
24,910
|
28,851 |
| Current assets |
25,710
|
22,410
|
26,291 |
| Current liabilities |
9,183
|
7,227
|
12,041 |
| Equity capital |
16,066
|
14,970
|
14,302 |
| - share capital |
500
|
500
|
500 |
| Employees (average) |
5
|
6
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
57.0%
|
60.1%
|
49.6% |
| Turnover per employee |
12,724
|
10,901
|
13,948 |
| Profit as a percentage of turnover |
11.8%
|
10.8%
|
10.3% |
| Return on assets (ROA) |
26.7%
|
28.3%
|
24.9% |
| Current ratio |
280.0%
|
310.1%
|
218.3% |
| Return on equity (ROE) |
46.9%
|
47.0%
|
50.1% |
| Change turnover |
-1,787
|
-4,330
|
16,621 |
| Change turnover % |
-3%
|
-6%
|
31% |
| Chg. No. of employees |
-1
|
1
|
0 |
| Chg. No. of employees % |
-17%
|
20%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.